Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Operating income | -$12.5M | -$22.2M | -$30.3M | -$35.5M | -$27.2M | -$25.3M | -$44.5M | -$41.5M |
| Net income | -$12.7M | -$20.6M | -$30.1M | -$36.2M | -$28.3M | -$26.2M | -$17.7M | -$36.2M |
| EPS (diluted) | $7.62 | $3.66 | $1.30 | $1.39 | $0.95 | $5.10 | $58.31 | $22.19 |
| Fiscal year | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$11.3M | -$17.6M | -$24.4M | -$27.6M | -$29.1M | -$21.3M | -$37.0M | -$26.4M |
| Capital expenditures | $137K | $1.31M | $1.01M | $3.68M | $112K | $50.0K | $30.0K | $2.00K |
| Free cash flow | -$11.4M | -$18.9M | -$25.5M | -$31.3M | -$29.2M | -$21.3M | -$37.0M | -$26.4M |
| Fiscal year | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $8.60M | $72.3M | $36.5M | $62.1M | $31.3M | $14.9M | $16.9M | $4.36M |
| Total assets | $45.3M | $92.1M | $70.4M | $78.0M | $45.5M | $25.0M | $43.2M | $5.78M |
| Total liabilities | $41.0K | $871K | — | — | — | — | — | — |
| Long-term debt | — | — | — | $14.4M | $10.6M | $5.40M | — | — |
| Shareholders' equity | $42.8M | $84.5M | $57.5M | $47.5M | $21.0M | $3.08M | $24.1M | -$1.30M |
| Retained earnings | -$1.02K | $346K | — | — | -$137M | -$163M | -$181M | -$217M |
| Shares (wtd avg diluted) | 2.31M | 22.9M | 23.3M | 26.0M | 29.9M | 5.13M | 758K | 1.63M |
Every figure is extracted from BiomX Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.